Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | GLP1R | P43220 | 2/20 | 0.43 |
| ▸ | NTSR2 | O95665 | 7/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 7/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.43 |
| ▸ | EDNRA | P25101 | 1/20 | 0.43 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30350806 | 0.86 | OPRM1 (0.57) | OPRM1OPRD1OPRK1KISS1R | |
| SCHEMBL29635074 | 0.86 | F2 (0.59) | F2GLP1R | |
| SCHEMBL30728852 | 0.84 | OPRM1 (0.52) | F2OPRM1OPRD1OPRK1GLP1R | |
| SCHEMBL29986177 | 0.84 | OPRM1 (0.52) | F2OPRM1OPRD1OPRK1GLP1R | |
| SCHEMBL16507827 | 0.83 | ACE (0.49) | F2KISS1R | |
| SCHEMBL31275672 | 0.82 | KISS1R (0.47) | F2OPRM1OPRD1NTSR2NTSR1 | |
| SCHEMBL30536319 | 0.82 | F2 (0.46) | F2GLP1RKISS1R | |
| SCHEMBL29450325 | 0.82 | OPRM1 (0.53) | F2OPRM1OPRD1OPRK1GLP1R | |
| SCHEMBL15272531 | 0.81 | OPRM1 (0.50) | OPRM1OPRD1NTSR2NTSR1KISS1R | |
| SCHEMBL15272522 | 0.81 | OPRM1 (0.50) | OPRM1OPRD1NTSR2NTSR1KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441760-B2 | Amino diacids containing peptide modifiers | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2025-10-14 | — | — | US | disclosed |
| US-20240002433-A1 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2024-01-04 | — | — | US | disclosed |
| US-11634455-B2 | Amino diacids containing peptide modifiers | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441760-B2 | Amino diacids containing peptide modifiers | PTMS, PEPD, NGLY1 | F2 599/4885OPRM1 3667/4885OPRD1 2922/4885 |
| US-11634455-B2 | Amino diacids containing peptide modifiers | PTMS, PEPD, VIP | F2 551/4885OPRM1 3643/4885OPRD1 2840/4885 |
| US-20240002433-A1 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | PTMS, PEPD, NGLY1 | F2 599/4885OPRM1 3667/4885OPRD1 2922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.